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Albumin and fibrinogen show no binding affinity to varied molecular weights ofhepafin at physiological 
pH. Human plasma fibronectin was shown to bind heparins in both the solution and adsorbed states. 
Fibronectin was shown to have six active binding sites for heparins which may be stericaUy blocked in 
some adsorbed states. 125I-Fibronectin monolayer concentrations were shown to be significantly different 
on polyvinyl chloride surfaces when compared to hydrophilic/hydrophobic silica, Biomer, Silastic, and 
polystyrene surfaces. Preadsorbing fibronectin to various ubstrates and then allowing heparins to interact 
with the protein monolayer made it possible to bind up to 0.2 t~g/cm 2 heparin in a plasma environment. 
This fibronectin-heparin complex was at least 85% stable in plasma nd buffer solutions for up to 8 h 
time. The complex was observed to prolong blood clotting times two to three times over that of controls 
as assayed by Activated Partial Thromboplastin Times. All of the bound heparin was observed to be 
active by its ability to bind Factor X, in plasma. Monolayers of blood proteins adsorbed from human 
serum were not observed to be active in binding heparins. The fibronectin-heparin co jugate showed 
low activation of blood components compared to protein monolayers preadsorbed from human sera as 
assayed by Activated Partial Thromboplastin Time. © 1986 Academic Press, Inc. 
INTRODUCTION 
Great advances have been made during the 
past decade toward the concept of  rendering 
biomaterials nonthrombogenic  (1, 2). It has 
been proposed that relationships exist between 
the blood compatibi l i ty of  foreign substrates 
and substrate characteristics, uch as surface 
charge, hydrophilicity, surface-free energy, and 
surface protein interactions (3), Probably the 
most important  unresolved problem with 
blood-contact ing devices is that these devices 
are not as biologically compatible (inactive) 
with blood as b lood is with the endothel ial  lin- 
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ing of the vessels. When blood contacts med-  
ical devices or foreign surfaces, surface acti- 
vation of  the blood components  occurs. Un-  
interrupted, thrombosis  will follow. 
Several areas of  intense research exist as to 
how to most effectively render a blood-con- 
taining surface nonthrombogenic.  These in- 
clude blood compatibi l i ty via: (a) mutual ly  
compat ib le modul i  of  the implant  (medical 
device) and the surrounding tissue so as not 
to traumatize the blood (4); (b) control l ing the 
concentrat ion and species of  the adsorbed 
proteinaceous monolayer; (c) stopping platelet 
adhesion, retention, and/or  degranulat ion fol- 
lowing adhesion; and (d) stopping fibrin for- 
mat ion or destroying the crosslinked fibrin clot 
superstructure. Researchers using the ap- 
proaches of  (b) or (c) have shown that albu- 
minated surfaces or surfaces with an abun- 
dance of  a lbumin preferential ly adsorbed to 
them tend to be less thrombogenic  than those 
314 
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with a relative abundance of absorbed fibrin- 
ogen or gamma-globulin (y-globulin) (3, 5- 
7). In these studies, platelet adherence to ad- 
sorbed albumin and other adsorbed nongly- 
coproteins did not occur, due possibly to a 
lack of carbohydrate moieties, which are plen- 
tiful in fibrinogen and 7-globulins (8). Platelet 
adhesion and the resultant morphological 
changes eem to be determined both by the 
composition and the conformation of the 
initially adsorbed protein monolayer (9). 
The preferential dsorption of albumin, or 
maintenance of a preadsorbed albumin 
monolayer requires that implanted surfaces be 
passive to most proteins yet "recognize" al- 
bumin and bind to it (10). This usually re- 
quires surface modification since most surfaces 
do not preferentially adsorb albumin ( 11-15). 
Methodology (a) above is unique in that it 
ignores most of the surface ffects associated 
with blood-containing devices and instead fo- 
cuses upon the bulk properties of the substrate 
to inhibit surface-induced thrombosis. The 
hypothesis i  that moduli differences are what 
the body responds to in the activation of the 
intrinsic coagulation pathway. This method- 
ology, like (b), requires new or modified ma- 
terials to obtain the required bulk and surface 
characteristics. 
The methodologies li ted in (c) and (d) are 
accomplished by inhibiting platelet adhesion 
and aggregation and fibrin formation via 
pharmaceutical approaches. Using platelet and 
coagulation i hibitors, in conjunction with the 
medical devices, it is possible to improve blood 
compatibility by blocking the inherent mech- 
anisms that are the driving force for these nor- 
mal physiological functions. However, sys- 
temic usage of these inhibitors at physiologi- 
cally necessary concentrations could prove 
fatal; i.e., vascular hemorrhage would remain 
unchecked by both coagulation or platelet 
adhesion. Recognition of this problem has re- 
sulted in several unique and innovative ap- 
proaches for local delivery of small doses of 
either platelet inhibitors, coagulation i hibi- 
tors, or both, in concentrations too low to have 
bulk effect (16). The most prevalent drug being 
currently delivered in this fashion is heparin. 
However, prostaglandins and urokinase (17) 
have also been utilized successfully for their 
antiplatelet and fibrinolytic activities, respec- 
tively. 
A novel approach by Henninck et al. (18) 
to evaluate both antiplatelet activity and an- 
ticoagulation has been made utilizing the nat- 
ural driving force of protein adsorption to de- 
crease surface-free nergy. Heparin is delivered 
onto a medical device using the protein which 
itself reduces platelet adhesion (7, 19-21). In 
this methodology, heparin is covalently bound 
to albumin and preadsorbed to implantable 
polymers. The albumin coverage inhibits 
platelet adhesion and retention on the sub- 
strate surface while the immobilized heparin 
inactivates the coagulation cascade on a lo- 
calized level. 
Using this last approach as a type model, it 
may be possible to improve upon it by pread- 
sorbing blood proteins, that have a natural af- 
finity to heparin, onto medical grade materials. 
Heparin is then bound to the adsorbed protein 
monolayer insufficient quantity to cause a lo- 
calized inhibition of the coagulation cascade 
and a resultant depressed platelet response. 
The advantages of this technique are several 
fold: (i) there is no compromising ofthe hep- 
arin or protein structure by covalenfly altering 
either one; (ii) there is no compromising of 
the substrate surface or extended chemistries 
to covalenfly ink the heparin or protein to the 
surface of interest; (iii) the adoption of a "nat- 
urally" occurring physiological phenomenon; 
(iv) no toxicological side effects from extra- 
neous chemical reactions; (v) no chemical 
modification of the surface of interest--this 
allows for choices of materials with desirable 
mechanical properties without worrying about 
needed preferential dsorption of specific pro- 
teins; and (vi) ease of preparation. In case (iii) 
the naturally occurring adsorption of serum 
proteins is used to reduce the surface nergy 
of a blood-contacting medical device followed 
by affinity binding of heparin to the protein. 
This process (iii) and resultant protein-heparin 
ligand may not be physiologically viewed as 
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an antigen thereby having antibodies produced 
against it. 
MATERIALS AND METHODS 
Biomer (Ethicon Inc., Somerville, N.J.) was 
received as a 30% by weight (w/v) solution in 
N,N-dimethylacetamide (DMAC). The solu- 
tion was diluted to a 15% (w/v) solution in 
DMAC (Baker Chemical, Phillipsburg, N.J.) 
and precipitated in distilled water. The poly- 
mer precipitate was thoroughly washed, dried, 
and vacuum-dessicated for 12 h at room tem- 
perature. The dried polymer precipitate was 
stored in the dark, at room temperature, in a 
dry glass container. This polymer precipitate 
was the stock of Biomer for the entire study. 
Polyvinyl chloride (Bentley Laboratory Inc., 
Irvine, Calif.) was supplied in the form of 
"Implant-Tested" cardiovascular bypass tub- 
ing. Upon receipt, the tubing was stripped of 
all inked impressions by cutting those sections 
out and discarding them. The remainder was 
cut into small pieces and stored in the dark in 
a dry glass container at room temperature. 
Polystyrene (Coming Glass, Coming, N.Y.) 
was supplied as sterile culture dishes or as 1.00- 
mm spherical beads (Sinclair-Koppers Co.). 
Polystyrene (PS) was chosen as a reference 
material due to its chemical similarity to pure 
PVC and since it is available in relatively large 
pure quantities. The PS beads were used as 
received, whereas the culture dishes were 
granularized and stored in the dark in dry glass 
containers at room temperature. 
Polydimethylsiloxane (PDMSO) was sup- 
plied as nonreinforced medical grade subder- 
mal implant Silastic sheeting or as Medical 
Adhesive 891 (both from Dow Coming Corp., 
Midland, Mich.). PDMSO was chosen because 
of its current usage in the biomedical field as 
a common subdermal implant material. 
PDMSO, of which Silastic is a type, is also a 
reference material of the National Heart, Lung 
and Blood Institute (22). 
Fused amorphous ilica microscope slides 
and glass beads, 1.00 to 1.05 mm diameter (B. 
Braun Melsunger, Apperatebau), were utilized 
as reference hydrophilic substrates. The 
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chemical composition of these glass beads has 
been determined elsewhere (23). The chemical 
composition of the fused amorphous silica was 
considered to be 100% SiO2 and was verified 
via X-ray photoelectron spectroscopy. 
Serum albumin (human, Fraction V) was 
obtained from Sigma Chemicals, St. Louis, 
Mo. (A-2376). The albumin was stored des- 
sicated at 0°C. No further purification or 
chemical alteration was made to the albumin. 
Fibrinogen (bovine, 95% clottable) was ob- 
tained from Miles Laboratories, Elkhart, In- 
diana (Pentex R, Lot 28) and stored essicated 
at -20°C. No further purification or chemical 
alteration was attempted. 
Human plasma fibronectin was supplied 
frozen (-80°C) in Tris buffer (pH 7.4) in 1- 
ml aliquots as a generous gift from Dr. Deane 
F. Mosher (Department ofHematology, Uni- 
versity of Wisconsin). The fibronectin was 
stored at -80°C until used. 
Sodium heparin derived from porcine in- 
testinal mucosa was obtained from Diosynth 
Inc., Chicago, Ill. The heparin was stored des- 
sicated and refrigerated. The company assay 
listed the heparin to have an activity of 165 
units per milligram (USP) or 171.3 units per 
milligram as received. 
Solutions [10% (w/v)] of Biomer and poly- 
vinyl chloride were prepared by stirring resins 
in N,N-dimethylacetamide (spectral grade) for 
12 to 24 h. The polymer solutions were filtered 
(0.22 ~m) to remove particulates. The filtered 
solutions were cast against cleaned glass plates. 
These cast solutions were then heated to 50°C 
in a vacuum oven, at atmospheric pressure, 
for 24 h to drive off the solvent. The films 
were then stripped from the plates and re- 
placed in the heated vacuum oven (50°C, 20 
t~m Hg Torr) for 24 h to remove all residual 
solvents. 
A 10% (w/v) solution of polystyrene (PS) 
was made by stirring PS granules in dichlo- 
romethane (spectral grade) for 1 to 2 h. The 
PS solution was then filtered (0.22 tzm) and 
cast against clean glass plates. The cast solution 
was placed in a laminar flow hood for 24 h at 
room temperature to allow the solvent to 
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evaporate. The resultant rind films were then 
removed from the plate support and placed 
under heated vacuum (50°C, 20 um Hg Torr) 
for 24 h to remove any residual solvent. 
The substrate surfaces were cleaned follow- 
ing a protocol described elsewhere (24, 61, 62). 
The procedure was utilized to remove surface 
contaminants in the micron range and larger 
prior to experimental use. All materials were 
handled with gloved hands or with metal for- 
ceps and cleaning was done in a clean room 
free from micron-sized particles. 
Polystyrene beads, 1.00 mm diameter, were 
cleaned by the methodology of Coleman et al. 
(23). Polystyrene beads were placed in an 
extraction thimble (fat-extracted cellulose, 
Whatman) and refluxed in a Soxhlet extractor 
with petroleum ether (reagent) for 24 h fol- 
lowed by drying under heated vacuum (50°C, 
20 t~m Hg Torr) for at least 24 h. 
Cleaned fused amorphous silica slides were 
treated for 5 min in oxygen plasma produced 
by a Plasmod (Tegal Corp., Richmond, Calif.) 
according to the methodology of King et al. 
(24, 61). Slides prepared in this fashion were 
immediately used and were never stored for 
longer than eight hours in glass containers that 
had been cleaned in a similar fashion. 
In order to produce a more hydrophobic 
surface, previously cleaned and radiofre- 
quency glow-discharged silica slides were va- 
por-silanized according to the methodology of 
Hailer (25) using N-propyltriethoxysilane. This 
silanization procedure covalently inks the sil- 
ane groups to the surface of the silica slides, 
masking the hydrophilic silica surface. The re- 
sultant silica has N-propyltriethoxysilane co- 
valently attached to the surface (NPS-silica). 
Disposable polypropylene columns (0.8 
× 20.5 cm, Kontex, Vineland, N.J.) were cut 
to 2-cm lengths and packed with either cleaned 
glass beads (1.00 to 1.05 mm diameter) or 
cleaned polystyrene beads (1.00 mm diame- 
ter). The glass bead columns were then sub- 
jected to polymer solution treatments tocoat 
the beads with the desired polymer after a 
modification of the methodology of Brier- 
Russell et al. (26), described below. 
Solutions [1% (w/vi] of Biomer in spec- 
tral grade N,N-dimethylacetamide, polyvinyl 
chloride in N,N-dimethylacetamide (spectral 
grade), polystyrene in dichloromethane (spec- 
tral grade), and Silastic adhesive (uncured) in 
toluene (spectral grade) were prepared and 
stored in sealed glass containers in a dark en- 
vironment. These stock solutions were filtered 
(0.22 tsm) just prior to use. Using cleaned glass 
syringes, the solutions were injected slowly 
upward into the packed columns. The col- 
umns were continuously tapped to prevent or 
dislodge trapped air pockets. When the res- 
ervoir had approximately 5 ml of polymer so- 
lution, the solution was allowed to flow back 
down through the column, under gravity. The 
last remaining drops were then "wicked" from 
the bottom, via capillary action, with a clean 
dry cloth. Columns were stored covered at 
room temperature for 24 h to allow the solvent 
to evaporate. The columns were then placed 
under heated vacuum (50°C, 20/~m Hg Torr) 
for 24 h to remove all residual solvents. This 
solution injection/draining procedure was re- 
peated five times to insure complete polymeric 
coverage of the glass beads. 
Random columns were selected for obser- 
vation and characterization by scanning elec- 
tron microscopy and X-ray photoelectron 
spectroscopy. The columns were assumed to 
have a packing efficiency of 0.74 (a close- 
packed system) and thus a void volume of ap- 
proximately 0.8 ml. The volume of the col- 
umns was 1.0 cm 3 and, assuming only point 
contact between spheres, yielded an effective 
surface area of 50 cm 2 (27). 
All substrate materials were characterized 
according to a modified version of the sug- 
gested Level II characterization f surfaces by 
the National Heart, Lung and Blood Institute 
(22). The materials were subjected to light mi- 
croscopy, scanning electron microscopy, sur- 
face energetics characterization (Wilhelmy 
plate contact angle), and X-ray photoelectron 
spectroscopy (28, 29). 
The commercially available sodium salt of 
heparin was fractionated by gel permeation 
chromatography. 
Journal of Colloid and Interface Science, Vol. 111, No. 2, June 1986 
318 WINTERTON ET AL. 
Samples of low-molecular-weight (LMW), 
high-molecular-weight (HMW), and com- 
mercial sodium heparin were then character- 
ized by an independent laboratory. The mo- 
lecular weight was determined by high-per- 
formance (pressure) liquid chromatography 
(HPLC) using dextrans of various molecular 
weight as standards, according to the meth- 
odology of Hurst et al. (30). 
The free amine groups on heparin were re- 
ductively methylated using a modification of 
an earlier protocol (31) patterned after Jentoff 
and Dearborn (32). The radiolabeled heparin 
was then lyophilized and stored at - 10°C until 
used. Unless otherwise stated, all labeling pro- 
cedures had an effective degree of labeling of 
approximately 0.8 labels per molecule. 
Proteins of interest were iodinated using 
immobilized lactoperoxidase-glucose xidase 
with labeled sodium iodide. From 0.25 to 1.00 
g of protein was dissolved in 0.375 ml PBS, 
pH 7.4. A suspension of immobilized lacto- 
peroxidase and immobilized glucose oxidase 
(Enzymobeads, Bio-Rad, Richmond, Calif.) in 
0.25 ml distilled water (rehydrated 24 h prior 
to use) was added to the protein solution. 
Then, 1.0 mCi Na~25I (New England Nuclear, 
Boston, Mass.) was added (specific activity 
17.4 Ci/mg and concentration 100 mCi/ml) 
to this reaction mixture. Finally, 0.125 ml, of 
a freshly prepared solution of 1% (w/v)/3-D(+) 
glucose (Sigma) in water was added to the re- 
action solution. The solution was capped and 
allowed to stand unagitated for 30-35 rain. 
The reaction was stopped by passing the reac- 
tants through two previously characterized 
Sephadex G-25 columns. The labeled protein 
eluted entirely in the void volume while the 
Enzymobeads did not elute at all. The re- 
maining reactants and unwanted by-products 
eluted in the last portion of the total volume. 
The protein concentration was determined by 
UV spectroscopy (Perkin-Elmer Lamda 7 
UV-Vis spectrophotometer). All radiolabeled 
proteins were freshly prepared and were dis- 
carded after 24 h. All iodinations had a degree 
of labeling of approximately 0.5 labels per 
molecule. 
In order to insure that the iodination pro- 
cedure did not denature the proteins, all ra- 
dioiodinated proteins were characterized by 
ultraviolet spectroscopy, fluorescence spec- 
troscopy and polyacrylamide g l electropho- 
resis. The stability of the iodinated species, 
with respect o the substituted iodine, was de- 
terrnined and any quenching effects of the io- 
dine label on the fluorescence emission and 
UV absorbance was noted. 
Two systems of equilibrium dialysis were 
utilized to detect heparin binding to proteins 
in solution. The first was a system wherein 
dialysis tubing (Spectrapor 6,Spectrum Med- 
ical Industries, molecular weight cutoff25,000) 
was used to house both the protein and hep- 
arin, and the second was a system where the 
same dialysis tubing was cut into sheet form 
and clamped between two identical chambers. 
The advantage of the second method, when 
compared to the first, is that it was easier to 
insure that leakage into the buffer reservoir 
did not occur. The first system utilized a 2-ml 
reservoir and a 6-ml buffer surround. The sec- 
ond system consisted of two identical cham- 
bers of 5 ml volume ach separated by dialysis 
sheeting. 
The systems were characterized (33) in sep- 
arate control experiments by placing tritium- 
labeled heparins (LMW, HMW, and com- 
mercial sodium heparin) with phosphate- 
buffered saline (PBS), pH 7.4 (2 mM KH2PO4, 
8 mM Na2HPO4, and 145 mM NaC1), in the 
reservoirs and allowing them to diffuse until 
equilibrium was reached. 
Protein binding to heparin was determined 
for all three heparins by adding the proteins 
and 3H-heparin in the same reservoir (33) so 
that he final concentration f protein was 1.5 
X 10 -6 M. The final 3H-heparin concentration 
was 50, 25, and 10 tzg/ml, in separate xper- 
iments. The buffer was mildly stirred (system 
1) or the entire system was rotated gently (sys- 
tem 2) on a laboratory rotator for 24 h, at 
which time the samples were taken. The extent 
of binding and binding kinetics were deter- 
mined by comparing the amount of 3H-hep- 
arin on the reservoir side versus the unbound 
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TABLE I 
Contact Angle Results Using Wilhelmy 
Plate (Mean + SD) 
Material O ~  O~i~ 
Amorphous silica  
(n = 12) 0 ° 0 ° 
Amorphous ilica  
(Hydratedb; n = 4) 0 ° 0 ° 
Cleaned glass 
(n = 6) 3 _+ 5 ° 0 ° 
Cleaned glass 
(Hydrated; n = 6) 0 ° 0 ° 
Polydimethyl siloxane 
(n=4)  100_+ 1 ° 49_+2 °
Polydimethyl siloxane 
(Hydrated; n = 4) 104 _+ 4 ° 63 _+ 1 ° 
Polystyrene 
(n=3)  101_+ 10 ° 35_+6 °
Polystyrene 
(Hydrated; n = 4) 100 _+ 1 ° 32 _+ 2 ° 
Biomer 
(n=4)  104+ 1 ° 32+2 °
Biomer 
(Hydrated; n = 4) 84 + 11 o 20 + 1 ° 
Polyvinyl Chloride 
(n=4)  90+ 3 ° 40_+3 °
Polyvinyl chloride 
(Hydrated, n = 4) 96 + 0 ° 34 + 3 ° 
N-Pentyl silanized silicW 
(n=6)  76+ 1 ° 58_+ 1 ° 
a Radiofrequency glow discharge. 
b Hydrated refers to soaking for 24 h in phosphate- 
buffered saline. 
c Not studied hydrated ue to hydrolysis of silane groups. 
3H-hepar in concent rat ion  diffused to the 
buffer side. The amount  of  bound 3H-hepar in 
to prote in (C~ e°) is determined  by 
CBHep = f *Hep __ ¢~Hep 
• ~Res VBuffer [1] 
where 
CHep= Concent ra t ion  of 3H-hepar in re- Res 
main ing  in the reservoir 
= Concent ra t ion  bound 3H-hepar in 
+ Concent ra t ion  free 3H-hepar in in 
so lut ion 
c .ep  = Concent ra t ion  of  unbound 3H-hep- Buffer 
ar in diffused to the buffer side 
= Free hepar in  concent ra t ion  
3H-Hepar in  concentrat ions  were deter- 
mined  by l iquid scint i l lat ion count ing.  The 
b ind ing  constants  o f  3H-hepar in to protein 
were determined by Scatchard plots (35) which 
also yielded the number  of  b ind ing  sites (n) 
according to 
- nK -  KF  [2] 
[A] 
where 
= moles bound l igand (hepar in) /moles  to- 
tal prote in 
K = b ind ing  (association) constant  
[A] = l igand (heparin) concent rat ion  
n = number  of  identical,  non interact ing  
sites. 
Therefore, plott ing ~/[A] versus ~ yields a slope 
o f -K  and  an  intercept ofnk on the ~/[A] axis 
or n on the ~ axis. 
Prote in adsorpt ion onto  c leaned Biomer,  
polyv inyl  chloride, po lyd imethy ls i loxane (Si- 
lastic), amorphous  silica, and  polystyrene 
substrate disks was done in an  adsorpt ion cell. 
The cells themselves were 1-ml disposable cu- 
vettes capped with c lean 00 corks. Tygon tub-  
ing was in t roduced into bored holes in the 
corks and  stoppered on  the outer  ends with 
three-way stopcocks. 
Substrates were in t roduced into the cells 
with c lean forceps and  the cells then  corked. 
The closed cells were then pr imed with de- 
gassed PBS (pH 7.4) unt i l  all air was removed.  
The cells were al lowed to sit at room temper-  
ature for at least 1 h prior to the in t roduct ion  
of  labeled protein solut ion. Radio labeled pro- 
tein solut ions were then in t roduced by injec- 
TABLE II 
Molecular Weight Determination f Heparins 
(Mean _+ SD) 
Low molecular weight 7,600 
Medium molecular weight 
(n = 4) 14,800 + 3,700 
High molecular weight 
(n = 4) 27,700 + 8,600 
Commercial heparin 
(n = 4) 20,800 _+ 10,200 
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FIG. 1. Scatchard analysis of the solution binding of labeled heparins to proteins in solution. The values 
given are for commercial heparins but those for low-molecular-weight andhigh-molecular-weight heparins 
were not significantly different. Values are mean + SD (n = 6), fibronectin, slope = - 1,02, intercept =6.63, 
r = 0.82; albumin: slope = 0.59, r = 0.90; fibrinogen: slope = 0.036, r = 0.92. 
tion from clean disposable syringes. Ten mil- 
liliters of protein solution was injected into 
the cell at the rate of 40 ml/min to remove all 
priming buffer and to introduce the protein 
solution in desired concentrations. Care was 
taken so as not to introduce any air into the 
system. The cells were then allowed to remain 
stationary, at room temperature, for up to 24 
h. To terminate protein adsorption each cell 
was flushed with 30 ml PBS buffer at 60 ml/ 
rain, to insure that the substrates were not re- 
moved through a protein-solution/air inter- 
face. Previous studies with priming solution 
of Blue Dextran 2000 (Pharmacia Fine 
Chemicals), using light spectroscopy (639 nm), 
indicated that the dextran was removed after 
a 5- to 6-ml flush, at 40 ml/min. Substrates 
were then removed and placed in dry scintil- 
lation vials. Adsorbed protein concentrations 
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were determined by gamma counting on a 
gamma radiation detector. 
Desorption of the protein from the sub- 
strates was determined by allowing pread- 
sorbed protein films to desorb in fresh PBS 
buffer, for up to 24 h, in new vials. The cells 
were then flushed to remove all desorbed pro- 
tein. Remaining protein concentrations were 
determined by 3' radiation counting. Verifi- 
cation of the concentration of initially ad- 
sorbed protein layer required that the desorbed 
protein solution, flushed at the termination of 
the experiment, be counted in similar fashion. 
Desorption of adsorbed radioiodinated 
proteins was also done in freshly prepared bo- 
vine platelet-poor plasma (PPP). Fresh whole 
slaughterhouse blood was collected and mixed 
in a 9:1 (v/v) ratio with a 3.8% (w/v) solution 
of sodium citrate (reagent grade) in water. PPP 
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TABLE III 
Values for 3H-Heparin Binding to Proteins ~ 
b Binding sites b 
Protein (g/litery ~ (n) 
Albumin 
Low-molecular-weight 
heparin ~-.0.00 - -  
High-molecular-weight 
heparin -0.15 - -  
Commercial heparin -0 .59 - -  
Fibrinogen 
Low-molecular-weight 
heparin ~0.00 - -  
High-molecular-weight 
heparin ~0.00 - -  
Commercial heparin ~0.00 - -  
Fibronectin 
Low-molecular-weight 
heparin 0.43 5.96 
High-molecular-weight 
heparin 1.10 6.32 
Commercial heparin 1.02 6.48 
an=3.  
b For confidence levels, see Fig. 1. 
was prepared by centrifugation f the whole 
blood for 20 min at 1300g force. PPP was then 
pipetted off and used immediately. The de- 
sorption experiments with PPP was the same 
as above, except hat PPP was used as the de- 
sorption medium. Flushing was still done with 
PBS buffer. Maximum desorption time was 
8 h with PPP. 
Native proteins were adsorbed onto clean 
Biomer, PVC, PS, PDMSO, and glass ubstrate 
disks (planchettes) from 0.3 mg/ml protein 
solution left for 24 h. After buffer flushing, 10 
ml of 0.1 mg/ml solution of either LMW, 
HMW, or commercial ~4C-heparin, in PBS, 
was injected into the cell. The lac-heparin 
was allowed to interact with the adsorbed 
protein layer for 1 h whereupon the cells were 
flushed with 30 ml PBS buffer at 60 ml/min 
to remove all desorbed protein and unbound 
heparin. The substrates were then air-dried at 
room temperature and the amount of bound 
~4C-heparin determined by counting on a 
"planchet type" gas ionization radiation de- 
tector (Internal Proportional Counter, Eber- 
line 2200) for 5 min (high voltage at 96.75 V, 
window at 96 V, and threshold at 40 V). 
Quantitation was clone by subtraction of 
CPM of 14C-heparins on controls (no adsorbed 
protein) from CPM of 14C-heparins bound to 
adsorbed protein substrates. This modified 
CPM was further corrected by dividing by the 
efficiency, found from a calibrated 7-source, 
yielding effective degradations per minute 
(DPM). This DPM value was then divided by 
the specific activity to yield the amount of 
14C-heparin bound. 
Previously prepared columns of polystyrene 
beads, glass beads, and polymer-coated glass 
beads of Biomer, polyvinyl chloride, and 
polydimethylsiloxane were primed, from the 
bottom, with PBS for 1 h. Excess buffer was 
then pipetted off and 10 ml of native protein 
solution (0.3 mg/ml) was introduced the same 
way as was the buffer. Proteins were allowed 
to adsorb for 24 h. After having excess protein 
solution pipetted from the column reservoir, 
the columns were then flushed with 30 ml PBS 
buffer. Solutions (0.1 mg/ml) of 14C-labeled 
heparin of commercial molecular weight, were 
then introduced, as above, in 10-ml aliquots 
and allowed to interact for up to 8 h. 
Kinetics of ~4C-heparin binding were mon- 
itored by solution depletion techniques. The 
stock 14C-heparin solution activity was com- 
pared to the activity of 100-#1 samples drawn 
from the bottom of the column. Activity and 
quantitation were accomplished by liquid 
scintillation counting. 
Release (desorption) of 14C-heparin was 
done in both PBS buffer and bovine platelet 
poor plasma (PPP). At binding equilibrium, 
the 14C-heparin solution was pipetted from the 
reservoir and the column flushed with 30 ml 
PBS buffer. Again, excess buffer was removed 
from the reservoir. At this time PBS buffer 
release of t4C-heparin was initiated. Samples 
were taken by injecting 1 ml PBS buffer from 
below and removing the same volume of buffer 
from the reservoir. Desorption was allowed for 
up to 24 h. 
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FIG. 2. '251-Albumin static adsorption isotherms on disks taken at room temperature. Values given are 
mean + SD (n = 3) for all points except 0.3 mg/ml, where n = 9. (a) Biomer, (b) Silastic, (c) polystyrene, 
(d) polyvinyl chloride. 
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Release of 14C-heparin in bovine PPP was 
done as above except that PPP was introduced 
by a second flush of 20 ml plasma to remove 
excess PBS buffer. Samples were taken in a 
similar manner. Plasma release studies were 
done for up to 8 h. 
All plasma nd buffer samples were counted 
by liquid scintillation counting. 
The total amount of 14C-heparin released 
could be due to: (a) released 14C-heparin from 
nondesorbing protein, CR; and (b) "released" 
heparin still bound to desorbed protein, CB. 
If CB is equal to the amount of desorbed pro- 
tein (Cp) (previously determined) then the true 
amount of 14C-heparin actually released from 
protein, C, is given by 
C = C.  - Cp [3] 
where 
CH=CR+CB 
= Amount determined by liquid scintil- 
lation counting. 
Fresh human whole blood was obtained 
from healthy donors and immediately mixed 
in a 9:1 (v/v) ratio with a 3.8% (w/v) solution 
of sodium citrate (Reagent grade). Platelet 
poor plasma (PPP) was obtained by centrifu- 
gation of the whole blood for 10 min at 2200g 
force. The PPP was decanted offand used im- 
mediately or stored frozen for up to 2 weeks. 
Human PPP was introduced into buffer 
primed Biomer columns according to the 
methodology previously discussed. PPP was 
allowed to remain in the columns for 1 h to 
allow for plasma protein adsorption, then the 
columns were flushed with 30 ml PBS (pH 
7.4) at approximately 60 ml/min. Solutions of 
commercial lac-heparin (0.1 mg/ml) were in- 
troduced and the kinetics of binding moni- 
tored for up to 24 h via solution depletion. 
Release of 14C-heparin was done as previously 
described in both PBS buffer and human PPP. 
Activated partial thromboplastin time 
(APTT) and anti-Xa assays (34) were per- 
formed to determine the activity/presence of 
the bound and/or eleased heparins from sub- 
strates coated with plasma fibronectin and 
pooled human PPP. 
RESULTS AND DISCUSSION 
The substrate surfaces characterized were 
clean. There were no observed particulates or 
chemical impurities in the matrix. Most of the 
surfaces were macroscopically smooth. How- 
ever, some roughness was observed on Biomer, 
Silastic, polystyrene beads, and glass bead sur- 
faces at high magnification (36). All surfaces 
were wettable to different extents (see Table I) 
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FIG. 3. ~25I-Fibrinogen static adsorption isotherms on disks taken at room temperature. Values are mean 
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as indicated by the receding angle observed 
via Wilhelmy plate energetics. The substrate 
surfaces were clean and chemically accounted 
for by XPS examination. The solution tech- 
nique of coating the glass bead supports was 
shown to be complete by scanning electron 
microscopy and XPS analyses (36). 
Utilizing high-pressure liquid chromatog- 
raphy, the fractionated heparins were char- 
acterized by reference to known dextran mo- 
lecular weights. This methodology yields the 
molecular weight relative to dextrans; there- 
fore, the absolute molecular weights are still 
unknown. Another disadvantage to this 
methodology is that the molecular weight dis- 
tribution (i.e., weight average molecular 
weight, number average molecular weight) re- 
mains unresolved. However, the relative val- 
ues were consistent and thus considered reli- 
able. Since heparins are chain-like structures 
and not globular in nature, like dextrans, it 
was necessary to multiply the values obtained 
by an empirically derived factor (30) to com- 
pensate and yield more "accurate" relative 
molecular weights. The results are listed in 
Table II for LMW fractions, medium-molec- 
ular-weight fractions (not utilized), and HMW 
fractions. The average molecular weight for 
commercial heparin was determined from the 
values listed. 
The optical properties of the labeled pro- 
teins, studied here, which are indicative of 
conformation, seem to be identical to the na- 
tive proteins (36). Also, the electrophoretic 
mobility was unchanged, which indicates im- 
ilar conformation and that no fragmentation 
occurred during iodination (64). Even so, it 
still cannot be concluded that the iodinated 
protein is equivalent to the native structure. 
Indeed, iodide has a relatively large atomic ra- 
dius and is extremely large when compared to 
the hydrogen atomic size that it has been sub- 
stituted for. In this study the iodination per- 
formed was done under conditions much 
milder than the manufacturers' recommen- 
dations for iodination and the resultant spe- 
cific labeling was much lower than those re- 
ported by the manufacturers. Since there was 
only up to one label per protein considered 
(usually only 0.5), it is highly unlikely that the 
same tyrosine is labeled every time in the re- 
spective proteins considered. This being the 
case, perhaps the localized iodine effects are 
either masked by the large surrounding host 
or so small that accommodation by the rela- 
tively immense protein is accomplished with- 
out any macroscopically observable effects. In 
either case, one may be certain that the elec- 
tronegativity and size of the iodide substitution 
has a massive localized effect. It is assumed 
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that this localized effect can be negated for our 
purposes since no preferential adsorption/re- 
jection of iodinated proteins was observed in 
this study. 
The binding oftritiated heparin fractions to 
albumin, fibrinogen and fibronectin was ex- 
amined via equilibrium dialysis. The results 
are given in Fig. 1. The resultant values for 
HMW and LMW 3H-heparin fractions were 
not significantly different from commercial 
heparin, in any instance. The association 
(binding) constant (Kassoo) for albumin- 
3H-heparin is from approximately 0 to -0.5 
(g/liter) -I indicating a mutual nonaffinity of 
3H-heparin and albumin. Fibrinogen shows 
similar results with Ka~o~ being equal to zero--  
a noninteraction or nonassociation between 
3H-heparin and fibrinogen. Figure 1 further 
shows the rather strong affinity of 3H-heparin 
for plasma fibronectin. Kassoc is nearly equal 
to unity and the number of binding sites (n) 
is equal to 6. The negative slope on a straight 
line (fit by linear regression, R = 0.82) is in- 
dicative of noncooperative binding of six in- 
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dependent sites. Fibronectin has been shown 
(37-41) to have three binding sites for heparin 
on each of its two segments. Thus, the binding 
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of six heparins per fibronectin molecule, in 
solution, indicates that in the "native" solution 
state that all six sites are active in binding. 
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While it is customary to report K~soc in 
terms of moles per liter (M), due to the poly- 
dispersity ofheparin and the heparin fractions 
used herein, it was felt that reporting Kassoc in 
terms of grams per liter is much more descrip- 
tive (see Table III). 
In this study, each adsorption was run at 
least three times using ratios of labeled to un- 
labeled protein of approximately 1:4, 1:2, and 
1:1 to determine the effect of protein labeling 
on adsorption. Each of the labeled protein 
fractions had approximately equal degrees of 
labeling (approximately 0.5). No increase in 
adsorption was observed with increased la- 
beled-protein concentration. All adsorption 
values were within the error limits of gamma 
counting efficiency. The preferential and non- 
preferential adsorption of the same labeled 
species has been shown to be substrate (system) 
dependent (7, 42). For example, in this study, 
iodinated (iodine-125) albumin was shown to 
nonpreferentially adsorb to polystyrene while 
others have shown preferential adsorption 
onto polystyrene latices (43). Those latices 
were well oriented with respect to charge and 
backbone, while the polystyrene utilized 
herein was random in nature. Conjugated al- 
bumin has also shown no preferential adsorp- 
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tion onto amorphous silica, Biomer, Silastic, 
and cellulose acetate (7). Similarly, concerning 
labeled fibrinogen, this study showed no pref- 
erential adsorption while others (7) have 
shown preferential dsorption elsewhere. It 
should be noted, however, that hese substrate 
surfaces here are different han those previ- 
ously reported. 
Figure 2 shows the adsorption isotherms of 
125I-labeled albumin on the polymeric sub- 
strates utilized. The adsorbed amount, for a 
0.3 mg/ml solution ofiodinated albumin, falls 
very near to the reported values of others (44- 
50) and nearly equal to the approximate 0.7 
#g/cm 2 monolayer concentration reported on 
polystyrene and polyurethane substrates (45, 
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46). Assuming that the iodinated albumin un- 
dergoes no multilayering, significant structural 
changes upon adsorption, and that surface ir- 
regularities can be neglected (36) on the 
polyvinyl chloride (PVC) or Silastic surfaces, 
then this study's albumin coverage on the 
substrates can be taken as follows: (a) polysty- 
rene, 97% coverage; (b) PVC, 77% coverage; 
(c) Silastic, 86% coverage; and (d) Biomer, 
100% coverage. Adsorption of albumin to a 
lesser extent on polyurethanes or polystyrenes 
under similar conditions has also been shown 
elsewhere (45). 
The isotherms of iodine-labeled fibrinogen 
(Fg) are shown in Fig. 3. The adsorption values 
are similar to those reported in the literature 
(45, 51) and the similar lack of a saturated 
monolayer on the surface at these concentra- 
tions is well depicted. Monolayer coverage is 
reported to be in the range of 0.8 to 1.2 ~g/ 
cm 2 for Fg. If a 1.0 ~zg/cm 2 coverage is taken 
as 100% monolayer coverage, then the per- 
centage coverage of Fg on these substrates can 
be given as: (a) polystyrene, 59%; (b) PVC, 
79%; (c) Silastic, 59%; and (d) Biomer, 59%. 
Iodine-labeled fibronectin (Fn) adsorption 
isotherms are given in Fig. 4 for the polymeric 
substrates and hydrophilic silica. The values 
listed are comparable to those given in the lit- 
erature (52-60) using similar concentrations. 
Except for the complete isotherms given by 
Bornzin and Miller (50), much of the adsorp- 
tion work has ignored the possibilities of pref- 
erential adsorption of labeled Fn and/or the 
air-solution interface. These problems, in ad- 
dition to incompletely characterized sub- 
strates, results in a large uncertainty as to ac- 
tual monolayer coverage values. Therefore, the 
values of Fig. 4 will be assumed to be 100% 
monolayer coverage, since no preferential d- 
sorption was seen to occur in this study. The 
large difference in plateau values of the sub- 
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strates, as compared to PVC, could be ex- 
plained by the occurrence of a conformational 
change in Fn upon adsorption onto PVC (dis- 
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cussed below), This accommodation f Fn in- 
creases the total amount of Fn present on the 
PVC surface. Such a change was reported ear- 
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lier for Fn adsorption onto hydrophobic silica 
surface (53, 61). 
Figure 5 shows kinetics of adsorption for 
125I-Fn. In all cases steady-state values were 
reached within 2 h, except for hydrophilic sil- 
ica and within 1 h for adsorption onto PVC. 
125I-Fn adsorption onto PVC can be fit to an 
ideally controlled process by diffusion, for the 
first 30 min. Thereafter, for the next 5 to 7 
rain a change in the type of adsorption was 
seen and then the onset of steady state fol- 
lowed. This pattern was quite similar to the 
pattern observed in the total internal reflection 
fluorescence (TIRF) mode for hydrophobic 
NPS-silica except for the concentration of Fn 
adsorbed under those conditions was calcu- 
lated to be much less (61). In the TIRF mode, 
the Fn adsorbed onto the hydrophobic silica 
was observed to be in a different environment 
(conformation) than that on the hydrophilic 
silica. It was thus hypothesized that this con- 
formational change accounted for the in- 
creased accommodation of Fn on the hydro- 
phobic silica surface. It is probable then that 
the differences in the adsorption rate and con- 
centration of Fn on PVC, as compared to the 
other substrates was due to it also being in a 
different conformation on that substrate. It is 
interesting to note that the adsorption kinetics 
of ~25I-labeled Fn onto hydrophilic silica ap- 
pears very similar to the second time phase of 
the TIRF monitoring of Fn adsorption on the 
same surface (61). The static adsorption 
seemed to take longer; however, this was not 
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(d) PVC, (e) hydrophilic glass. 
unexpected since no flow or turbulent con- 
vection were occurring in the static cell which 
would aid in mass transport to the surface or 
through the diffusional boundary layer• These 
static adsorption kinetics were very similar to 
those reported in the literature for monitor ing 
Fn adsorption by T IRF under static condi- 
tions (62). 
It is tempting to say that most  of  the static 
adsorption processes depicted here deviate 
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Protein a n d  
substrale 
Concentration of 
bound hepariu Molar ratio: Release in PBS 
(~g/cm 2) heparin to protein (24 h), % 
Solution Concentration of Solution 
depletion Ionization adsorbed protein depletion Ionization 
technique technique (#g/cm 2) technique technique 
Release in plasma 
(8 h), % 
Protein Heparin Protein Heparin 
Fn  
Silastic 
PS 
PVC 
Biomer 
Hydrophilic 
Silica 
Fg 
Silastic 
PS 
PVC 
Biomer 
Albumin 
Silastic 
PS 
PVC 
Biomer 
0.11 0.11 0.35 5.8:1.0 5.8:1.0 12 
0.10 0.09 0.31 6.0:1.0 5.5:1.0 18 
0.14 0.15 1.68 1.5:1.0 1.6:1.0 65 
0.11 0.11 0.34 5.5:1.0 6.0:1.0 10 
0.11 - -  0.30 6.6:1.0 - -  10 
0 - -  0.59 0:1 - -  14 
0 - -  0.59 0:1 - -  7 
0 - -  0.79 0:1 - -  22 
0 - -  0.64 0:1 - -  15 
0 0 0.60 0:1 0:1 18 
0 0 0.68 0:1 0:1 22 
0 0 0.52 0:1 0:1 12 
0 0 0.84 0:1 0:1 15 
0.9% 5.3% 
1.3% 16 11.5% 
0.9% 8 6.1% 
1.0% 47 17.0% 
10 
0.9% 15 6.9% 
m 
m 
m 
m 
m 
m 
61 
6 
12 
21 
63 
38 
20 
22 
a Data derived from Figs. 1-8. 
from an ideal diffusion-controlled process. 
This cannot be said for certain, however, since 
the first samples were taken (experiments er- 
minated) after 15 rain of adsorption time. It 
is probable that diffusion does have a part in 
the very early stages of the adsorption process 
(63) only it was not observed here due to the 
sampling protocols. 
Desorption of adsorbed 125I-Fn monolayer 
films is shown in Fig. 6 in buffer and plasma 
solutions. The monolayers were adsorbed 
from 0.3 mg/ml solutions of radiolabeled pro- 
tein. Fibronectin shows significant losses on 
PVC surfaces with both PBS and plasma. 
However, the other surfaces how only a t0 
to 15% loss in PBS and plasma. 
The adsorbed Fn generally appears quite 
stable. The PVC, however, shows FIN mono- 
layer losses of 40% in plasma nd 60% in PBS 
buffer. This is due perhaps to the nature of the 
adsorption process. Adsorbing quite rapidly 
(diffusion controlled), the protein may be in 
a conformation that is a steady-state equilib- 
rium with the Fn "sink," yet not in a preferred 
orientation. Under desorption conditions, this 
steady-state condition is no longer the equi- 
librium state and thus the surface concentra- 
tion is reduced considerably possibly to ac- 
commodate r orientation. 
The kinetics of binding and release of 14C- 
labeled heparin with Fn-coated substrates are 
shown in Figs. 7 and 8, respectively. 14C-hep- 
arin solutions were not observed to be signif- 
icantly depleted when passed over columns 
preadsorbed with monocomponent fibrinogen 
and albumin solutions, over the same period 
of time (36). 
The kinetics of binding for adsorbed fibro- 
nectin (see Fig. 7) show that steady state oc- 
curred in all cases within 1 h. The concentra- 
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TABLE V 
APTT Ass~ ~rHepafin A~vityonFn-Coated Dims 
Equivalent concentration 
Rel. units Time of heparin b
Substmte Heparin activity of heparin (s) (#g/cm 2)
Silastic None (n = 3) a 11.4 + 0.7 a 
LMW(n = 3) 0.03 24.5 _+ 3.9 0.18 
HMW (n = 3) 0.02 23.6 + 1.7 0.12 
Regular (n = 3) 0.02 23.5 + 2.9 0.12 
Biorner None (n = 3) a 32.0 +_ 6.9 a 
LMW (n = 3) 0.03 45.3 + 11.4 0.18 
HMW (n = 3) 0.02 44.4 + 13.1 0.12 
Regular (n = 3) 0.03 44.7 + 8.1 0.18 
PS None (n = 3) a 16.2 + 2.5 a 
LMW (n = 3) 0.03 29.5 + 4.7 0.18 
HMW (n = 3) 0.02 27.8 _+ 4.7 0.12 
Regular (n = 3) 0.03 28.7 _+ 3.6 0.18 
PVC None(n = 3) a 14.1 _+ 0.3 a 
LMW (n = 3) 0.05 27.9 + 5.5 0.30 
HMW (n = 3) 0.04 26.0 + 2.2 0.24 
Regular (n = 3) 0.05 27.4 + 1.9 0.30 
Human plasma-coated biomer Regular (n = 3) 0.00 35.8 + 7.3 0.00 
a Taken as zero. 
o Assuming 165 units/mg heparin. 
t ions of  14C-heparin bound to the adsorbed 
f ibronectin were approximately 90 to 150 ng 
per square cent imeter area. It is interesting to 
note that the "steady-state" results in a fairly 
straight line with a positive slope, when fit by 
l inear regression. The slopes vary from 0.14 
to 0.35. Glass, Biomer, and polystyrene all had 
constant steady-state slopes of  approximately 
0.25 while Silastic and PVC had slopes of  0.14 
and 0.35, respectively. It seems that since Fn 
desorbs from all of  these substrates that more 
scatter would be seen using a technique that 
measures the solution protein depletion, due 
to protein adsorption, and the concurrent 
protein desorpt ion from the same substrate. 
However, this was not observed. It remains to 
be elucidated whether the binding of  heparin 
to f ibronectin changes the sticking coefficient 
of  f ibronectin by allosteric binding of  the li- 
gand. 
Figure 8 shows the release of  bound 14C- 
heparin in PBS buffer and plasma. In all sys- 
tems, the total amount  of  released heparin did 
not equal that predicted by Eq. [3], which ac- 
counts only for released protein (see Fig. 6). 
This may be explained by several possible 
mechanisms of which two are discussed: (a) 
heparin binding to adsorbed f ibronectin alters 
the adsorbed protein sticking coefficient hus 
making it adhere more tenaciously to the var- 
ious substrates. Perhaps by allosterically bind- 
ing heparin to the adsorbed protein, the re- 
suiting conformational  change in the protein 
gives it a better "foot hold" on the substrate 
surface. This aUosteric hange in Fn induced 
by the binding of  heparin has been suggested 
(64, 65) for the mechanism by which fibro- 
nectin increases its abil ity to b ind to immo-  
bil ized collagen and complex solution phase 
collagen; (b) so lut ion-bound heparin may be 
released more readily and reorientat ion of  the 
protein monolayer  may accommodate  he re- 
binding of  the free heparin. This mechanism 
seems feasible for the PVC surface where Fn 
is apparent ly sterically hindered due to the 
high concentrat ion of  surface adsorbed Fn  in 
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comparison with other substrates; however, it 
is less likely for the other surfaces where the 
absorbed Fn is apparently more "spread out." 
In all cases, no more than 2% of the total 
~4C-heparin was released in PBS buffer and no 
more than 17% of the total 14C-heparin was 
released in the plasma environment. The great 
increase in the plasma release of 14C-heparin 
was probably due to the binding of heparin to 
blood factors rendering them inactive, and to 
the bacteriological and enzymatic attack of the 
protein monolayer or bound heparin. Ex- 
change of the adsorbed protein in plasma 
could also increase the amount of released 
heparin in a bound state to the original protein. 
The results of 14C-heparin binding protein 
monolayers as determined by gas ionization 
counting of the 14C-label are given in Table 
IV. For ease of comparison, the tabulated re- 
sults from Figs. 2 through 8 are also given. All 
six binding sites for heparin on fibronectin, as 
determined by Scatchard analysis, were active 
and available in the adsorbed state for all sub- 
strates except PVC. The increased concentra- 
tion of Fn adsorbed onto the PVC surfaces or 
its resultant different adsorbed conformation 
(64, 65) probably sterically blocked the ma- 
jority of the binding sites in that system. It 
appears that two heparin binding sites are hin- 
dered on both sides of the protein dimer and 
that a third may be hindered somewhat on 
one of the sides. Most likely, energy supplied 
by thermal fluctuations or convective turbu- 
lence probably renders this one semihindered 
site somewhat available for heparin binding. 
This explains the molar ratio of one fibronec- 
tin to approximately 1.5 heparin molecules. 
~4C-Heparin binding to the proteinaceous 
monolayer left after human serum interaction 
was not observed (36). In columns with surface 
areas up to 100 cm 2, the introduced 14C-hep- 
arin solution did not decrease in activity over 
a 24-h period. Assuming that the protein 
monolayer is at least as stable as a composite 
of the aforementioned monocomponent sys- 
tems (Table IV) of albumin, fibrinogen, and 
fibronectin in PBS (pH 7.4), the possibility of 
total protein desorption and thus undetected 
solution binding can be eliminated. After 
buffer flush, desorption/release was carried out 
in a buffer environment for 24 h or in a canine 
plasma environment for 8 h. All samples were 
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FIG. 10. Factor Xa assay for heparin released in plasma for column type adsorption. Values given are 
mean + SD (n = 3). (a) Biomer, (b) Silastic, (c) PS, (d) PVC, (e) hydrophilic glass. 
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equivalent to background counts or within the 
error of the standard eviation. Thus, it may 
be concluded that the proteinaceous mono- 
layer cannot bind heparin and, therefore, must 
contain very little fibronectin or inhibited fi- 
bronectin which is unable to bind heparins. 
Activated partial thromboplastin time 
(APTT) assays for heparin are generally con- 
sidered valuable; however, they are nonspecific 
in nature (66, 67) in that: (a) bound heparin 
and solution heparin may be treated equiva- 
lently and (b) any adsorption, and thus loss, 
of coagulation factors will prolong the resul- 
tant assay time. The results of APTT coagu- 
lation times done on plasma that had been in 
contact with polymer substrate discs, pre- 
treated with adsorbed Fn and bound heparin 
fractions, are given in Table V. The assay 
showed generally that all the prebound heparin 
was available for prolongation of coagulation 
times. The excessive prolongation ofsome ob- 
served clotting times is probably due to the 
depletion of coagulation factors (68). The de- 
pletion of these factors could occur by ad- 
sorption to container or substrate surfaces or 
inactivation by binding to either adsorbed or 
desorbed Fn molecules. If loss of coagulation 
factors were causing excessively prolongated 
coagulation times not accounted for by the 
heparin present, itwould be magnified in sys- 
tems with much larger surface areas. Figure 9 
shows prolongation of clotting times with in- 
creasing plasma contact time on column con- 
trol substrates preadsorbed only with fibro- 
nectin. The erratic behavior can be explained 
by the binding or adsorption and subsequent 
release or desorption with time, of coagulation 
factors. This behavior caused the scatter (SD) 
of times to be so great that the coagulation 
times could not be distinguished from those 
of the column substrate controls. Therefore, 
to determine the increase in coagulation times 
attributable tothe bound and released heparin 
from the column experiments, heparin color- 
imetric assays run concurrently or at the end 
of the plasma incubation of the substrate col- 
umns had to be done. 
Activated Factor X assay is very sensitive 
and specific for heparin in plasma environ- 
ments (34). The method involves the use of a 
chromogenic substrate ($2222) that is suscep- 
tible to the presence of Xa. Unknown concen- 
trations ofheparin are introduced which bind 
to known quantities of Xa. The Xa-heparin 
complex is inactive toward the $2222 sub- 
strate. The remaining Xa activity is quantitated 
by amidolysis of the $2222 substrate. The 
amidolysis stopped by the addition of acetic 
acid after a specified time. This methodology 
can detect 0.02 units of heparin per milliliter 
of plasma tested. 
Concurrent with APTT testing of plasma 
subjected to column substrates, each sample 
was tested, in duplicate, for released heparin 
activity via activated Factor X assay. The re- 
suits are given in Fig. 10 (also reference Table 
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IV and Fig. 8). The results correlated well with 
the data observed for heparin release in 
plasma. Small differences in the amounts of 
heparin released may be due to the different 
plasmas utilized in the two studies (bovine 
versus canine). 
CONCLUSIONS 
This in vitro study has shown several im- 
portant aspects relating to localized heparin 
delivery at a foreign surface-blood interface. 
First, albumin, albeit a cartier of metabolic 
by-products and some anticoagulants, does not 
bind heparin at physiological pH in solution 
or in the adsorbed state. The same can be 
stated for fibrinogen. Plasma fibronectin, on 
the other hand, binds heparin in either state. 
Fibronectin was shown to have six binding 
sites for heparin which may be sterically 
blocked if fibronectin adsorbs in such a fashion 
as to increase the surface concentration f the 
adsorbed protein. Next, it has been shown that 
by using adsorbed fibronectin as an interme- 
diate, it is possible to deliver heparin, pre- 
bound to the adsorbed protein, in concentra- 
tions up to approximately 0.2 ~g/cm 2 in a 
plasma environment. Also, active surface- 
bound heparin was maintained at approxi- 
mately 83 to 99% of original-bound heparin 
concentrations for up to 6 to 8 h time. The 
stability of the Fn monolayer was increased 
by the binding of heparin, probably due to an 
allosteric change upon binding the drug 
moiety, increasing the sticking coefficient of 
Fn (64, 65). 
It is also interesting to note that human 
serum, allowed to adsorb onto Biomer sur- 
faces, does not bind heparin even though fi- 
bronectin occurs in most healthy adults in the 
range of 300 to 500 t~g/ml plasma. Therefore, 
Fn appears not to be preferentially adsorbed 
from multicomponent systems. Or, if it is, it 
adsorbs from such systems in conformations 
unable to bind heparin. Comparing APTT re- 
sults of the fibronectin-precoated substrates 
bound to heparin, to controls precoated with 
human plasma or fibronectin alone, showed 
that the fibronectin-heparin surface does not 
increase the intrinsic activation of the coagu- 
lation cascade but rather increases the relative 
normal coagulation times two to three times 
over those observed with monocomponent 
human plasma or fibronectin. When the 
APTT results of this fibronectin-heparin 
complex are compared to the albumin-hep- 
arin covalent conjugate (7, 18-21), it can be 
seen that the times are similar, indicating that 
both are effective in prolonging clotting times. 
However, the comparison of direct times is 
not the important factor; rather that both tend 
to double or triple their clotting times relative 
to controls is significant. 
The trends observed throughout this section 
seem to indicate that the bound heparin is ac- 
tive in prolonging clotting times (APTT and 
Xa assays) and that the fibronectin adsorbed 
monolayer may indeed aid in reducing the in- 
trinsic activation of Factor XII. Furthermore, 
the amount of heparin remaining bound to 
the monolayer is greater than predicted by 
protein desorption alone. 
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